Update shared on09 Aug 2025
Fair value Increased 11%Despite a notable downgrade in consensus revenue growth forecasts, Somnigroup International’s price target has been significantly increased, reflecting higher valuation multiples and resulting in a fair value shift from $73.00 to $80.89.
What's in the News
- Somnigroup International completed a follow-on equity offering, raising $953 million by issuing 15,376,743 common shares at $62 per share with a $0.458 discount per share.
- Certain common stock will be under a lock-up agreement with directors and executive officers restricting sales for 31 days, requiring Goldman Sachs & Co. LLC consent for disposals.
- Q2 2025 earnings results are expected to be reported on August 7, 2025.
Valuation Changes
Summary of Valuation Changes for Somnigroup International
- The Consensus Analyst Price Target has significantly risen from $73.00 to $80.89.
- The Consensus Revenue Growth forecasts for Somnigroup International has significantly fallen from 16.3% per annum to 12.8% per annum.
- The Future P/E for Somnigroup International has risen from 27.00x to 29.56x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.